Health
Host tissue T cells play a previously unappreciated role in acute graft-versus-host disease – News-Medical.net
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor’s healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer.
Reviewed by Emily Henderson, B.Sc.Aug 28 2020
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor’s healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer. While this therapy can be life-saving, a major complication is the development of graft-versus-host disease (GVHD), which causes significant morbidity and can be fatal. Before allogenic HSCT, a patient receives a conditioning regimen, chemotherapy design…
-
General16 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News22 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General17 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News13 hours agoSerious traffic crash, Noosa – Sunshine Coast